Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 3/2008

01.06.2008 | Original Article

Lifetime Characteristics of Participants and Non-participants in a Smoking Cessation Trial: Implications for External Validity and Public Health Impact

verfasst von: A. L. Graham, Ph.D., G. D. Papandonatos, Ph.D., J. D. DePue, Ed.D., M.P.H., B. M. Pinto, Ph.D., B. Borrelli, Ph.D., C. J. Neighbors, Ph.D., MBA, R. Niaura, Ph.D., S. L. Buka, Sc.D., D. B. Abrams, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Detailed information about the characteristics of smokers who do and do not participate in smoking cessation treatment is needed to improve efforts to reach, motivate, and treat smokers.

Purpose

The aim of this study is to explore a broad range of characteristics related to participation in a smoking cessation trial.

Methods

Eligible smokers were recruited from a longitudinal birth cohort. Participants and non-participants were compared on a broad range of sociodemographics, smoking, psychiatric and substance abuse disorders, personality, and prospective measures from early childhood. Eligible smokers were compared to a matched regional subsample of the Behavioral Risk Factor Surveillance System (BRFSS).

Results

Few differences were observed, most of which were statistically significant but not clinically meaningful. Compared to non-participants, participants were more likely to be single, have lower income, be more nicotine-dependent, be more motivated to quit, and have higher levels of depressed mood and stress even after covariance of gender, income, and marital status. Sociodemographic differences between participants and the BRFSS sample reflect the skew toward lower socioeconomic status in the original birth cohort.

Conclusions

The encouraging conclusion is that smokers who enroll in cessation trials may not differ much from non-participants. Information about treatment participants can inform the development of recruitment strategies, improve the tailoring of treatment to individual smoker profiles, help to estimate potential selection bias, and improve estimates of population impact.
Literatur
1.
Abrams DB, Orleans CT, Niaura RS, et al. Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model. Ann Behav Med. 1996; 18: 290–304.PubMedCrossRef
2.
Centers for Disease Control and Prevention. Cigarette smoking among adults—United States, 2004. Morb Mortal Wkly Rep. 2005; 54: 1121–1124.
3.
Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000; 18: 305–311.PubMedCrossRef
4.
Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005; 28: 119–122.PubMedCrossRef
5.
McDonald PW. Population-based recruitment for quit-smoking programs: an analytic review of communication variables. Prev Med. 1999; 28: 545–557.PubMedCrossRef
6.
Glasgow RE, Klesges RC, Klesges LM, Somes GR. Variables associated with participation and outcome in a worksite smoking control program. J Consult Clin Psychol. 1988; 56: 617–620.PubMedCrossRef
7.
Linnan LA, Emmons KM, Klar N, et al. Challenges to improving the impact of worksite cancer prevention programs: comparing reach, enrollment, and attrition using active versus passive recruitment strategies. Ann Behav Med. 2002; 24: 157–166.PubMedCrossRef
8.
Mak YW, Loke AY, Lam TH, Abdullah AS. Predictors of the participation of smoking parents in a proactive telephone-based smoking cessation program. Addict Behav. 2006; 31: 1731–1743.PubMedCrossRef
9.
Holtrop JS, Wadland WC, Vansen S, Weismantel D, Fadel H. Recruiting health plan members receiving pharmacotherapy into smoking cessation counseling. Am J Manag Care. 2005; 11: 501–507.PubMed
10.
Pisinger C, Vestbo J, Borch-Johnsen K, Thomsen T, Jorgensen T. Acceptance of the smoking cessation intervention in a large population-based study: the Inter99 study. Scand J Public Health. 2005; 33: 138–145.PubMedCrossRef
11.
Fortmann SP, Killen JD. Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies. Am J Epidemiol. 1994; 140: 39–51.PubMed
12.
Pohl JM, Martinelli A, Antonakos C. Predictors of participation in a smoking cessation intervention group among low-income women. Addict Behav. 1998; 23: 699–704.PubMedCrossRef
13.
Klesges RC, Brown K, Pascale RW, et al. Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace. Health Psychol. 1988; 7: 575–589.PubMedCrossRef
14.
Kviz FJ, Crittenden KS, Warnecke RB. Factors associated with nonparticipation among registrants for a self-help, community-based smoking cessation intervention. Addict Behav. 1992; 17: 533–542.PubMedCrossRef
15.
Velicer WF, Keller S, Friedman RH, et al. Comparing participants and nonparticipants recruited for an effectiveness study of nicotine replacement therapy. Ann Behav Med. 2005; 29: 181–191.PubMedCrossRef
16.
Gritz ER, Berman BA, Bastani R, Wu M. A randomized trial of a self-help smoking cessation intervention in a nonvolunteer female population: testing the limits of the public health model. Health Psychol. 1992; 11: 280–289.PubMedCrossRef
17.
Brod MI, Hall SM. Joiners and non-joiners in smoking treatment: a comparison of psychosocial variables. Addict Behav. 1984; 9: 217–221.PubMedCrossRef
18.
Ahluwalia JS, Richter K, Mayo MS, et al. African American smokers interested and eligible for a smoking cessation clinical trial: predictors of not returning for randomization. Ann Epidemiol. 2002; 12: 206–212.PubMedCrossRef
19.
Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999; 89: 1322–1327.PubMed
20.
Glasgow RE, McCaul KD, Fisher KJ. Participation in worksite health promotion: a critique of the literature and recommendations for future practice. Health Educ Q. 1993; 20: 391–408.PubMed
21.
Abrams DB, Leslie F, Mermelstein R, Kobus K, Clayton RR. Transdisciplinary tobacco use research. Nicotine Tob Res. 2003; 5Suppl 1: S5–S10.PubMedCrossRef
22.
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.
23.
Niswander KR, Gordon M. The Women and Their Pregnancies: The Collaborative Perinatal Study of the National Institute of Neurological Diseases and Stroke. Washington: National Institute of Health; 1972.
24.
Broman SH. The collaborative perinatal project: an overview. In: Mednick SA, Harway M, Finello KM, eds. Handbook of Longitudinal Research. New York: Praeger; 1984: 182–215.
25.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991; 86: 1119–1127.PubMedCrossRef
26.
Piper ME, Piasecki TM, Federman EB, et al. A multiple motives approach to tobacco dependence: The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol. 2004; 72: 139–154.PubMedCrossRef
27.
Biener L, Abrams DB. The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991; 10: 360–365.PubMedCrossRef
28.
Abrams DB, Biener L. Motivational characteristics of smokers at the workplace: a public health challenge. Prev Med. 1992; 21: 679–687.PubMedCrossRef
29.
Curry SJ, Grothaus L, McBride C. Reasons for quitting: intrinsic and extrinsic motivation for smoking cessation in a population-based sample of smokers. Addict Behav. 1997; 22: 727–739.PubMedCrossRef
30.
Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992; 47: 1102–1114.PubMedCrossRef
31.
Buka SL, Shenassa ED, Niaura R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry. 2003; 160: 1978–1984.PubMedCrossRef
32.
Radloff LS. A new self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385–401.CrossRef
33.
Anda RF, Williamson DF, Escobedo LG, et al. Depression and the dynamics of smoking. A national perspective. JAMA. 1990; 264: 1541–1545.PubMedCrossRef
34.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983; 24: 385–396.PubMedCrossRef
35.
Cohen S, Lichtenstein E, Prochaska JO, et al. Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol. 1989; 44: 1355–1365.PubMedCrossRef
36.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychological Association; 1994.
37.
World Health Organization. Composite International Diagnostic Interview Computer Programs. Geneva: World Health Organization; 1990.
38.
Wittchen HU. Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994; 28: 57–84.PubMedCrossRef
39.
Wittchen HU, Robins LN, Cottler LB, et al. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry. 1991; 159: 645–653, 658.PubMedCrossRef
40.
Dierker LC, Donny E, Tiffany S, et al. The association between cigarette smoking and DSM-IV nicotine dependence among first year college students. Drug Alcohol Depend. 2007; 86: 106–114.PubMedCrossRef
41.
Andrews G, Peters L, Guzman AM, Bird K. A comparison of two structured diagnostic interviews: CIDI and SCAN. Aust N Z J Psychiatry. 1995; 29: 124–132.PubMedCrossRef
42.
Robins LN, Helzer JE, Croughan J, Ratcliff KS. National institute of mental health diagnostic interview schedule. Its history, characteristics, and validity. Arch Gen Psychiatry. 1981; 38: 381–389.PubMed
43.
Buka SL. “Learning Disabled Children Grown Up:” Natural history from birth through adulthood. DIS Newsletter. 1999; Winter.
44.
Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry. 1996; 37: 393–401.PubMedCrossRef
45.
Tellegen A. Brief Manual for the Multidimensional Personality Questionnaire. Minneapolis: University of Minnesota; 1982.
46.
Krueger RF, Caspi A, Moffitt TE, Silva PA, McGee R. Personality traits are differentially linked to mental disorders: a multitrait-multidiagnosis study of an adolescent birth cohort. J Abnorm Psychol. 1996; 105: 299–312.PubMedCrossRef
47.
McGue M, Slutske W, Taylor J, Iacono WG. Personality and substance use disorders: I. Effects of gender and alcoholism subtype. Alcohol Clin Exp Res. 1997; 21: 513–520.PubMed
48.
Wechsler D. Wechsler Intelligence Scale for Children. New York: The Psychological Corporation; 1949.
49.
SAS/STAT Software. Changes and Enhancements. Cary, NC: SAS Institute, Inc.; 2001.
50.
Shadel WG, Shiffman S, Niaura R, Nichter M, Abrams DB. Current models of nicotine dependence: what is known and what is needed to advance understanding of tobacco etiology among youth. Drug Alcohol Depend. 2000; 59Suppl 1: S9–S22.PubMedCrossRef
51.
Etter JF. Comparing the efficacy of two Internet-based, computer-tailored smoking cessation programs: a randomized trial. J Med Internet Res. 2005; 7: e2.PubMedCrossRef
52.
Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict Behav. 1994; 19: 33–39.PubMedCrossRef
53.
Hitsman B, Borrelli B, McChargue DE, Spring B, Niaura R. History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol. 2003; 71: 657–663.PubMedCrossRef
54.
Borrelli B, Bock B, King T, Pinto B, Marcus BH. The impact of depression on smoking cessation in women. Am J Prev Med. 1996; 12: 378–387.PubMed
55.
Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003; 71: 292–301.PubMedCrossRef
56.
Niaura R, Britt DM, Shadel WG, et al. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001; 15: 13–17.PubMedCrossRef
57.
Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction. 2006; 101: 1814–1821.PubMedCrossRef
58.
Buka SL, Tsuang MT, Lipsitt LP. Pregnancy/delivery complications and psychiatric diagnosis. A prospective study. Arch Gen Psychiatry. 1993; 50: 151–156.PubMed
59.
Zhu SH, Anderson CM, Tedeschi GJ, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002; 347: 1087–1093.PubMedCrossRef
60.
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005; CD001292.
61.
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005; CD001007.
62.
Glasgow RE, Klesges LM, Dzewaltowski DA, Estabrooks PA, Vogt TM. Evaluating the impact of health promotion programs: using the RE-AIM framework to form summary measures for decision making involving complex issues. Health Educ Res. 2006; 21: 688–694.PubMedCrossRef
63.
Kerner J, Rimer B, Emmons K. Introduction to the special section on dissemination: Dissemination research and research dissemination: How can we close the gap? Health Psychol. 2005; 24: 443–446.PubMedCrossRef
64.
Graham AL, Bock BC, Cobb NK, Niaura R, Abrams DB. Characteristics of smokers reached and recruited to an internet smoking cessation trial: a case of denominators. Nicotine Tob Res. 2006; 8Suppl 1: S43–S48.PubMedCrossRef
65.
National Institutes of Health State-of-the-Science conference statement. Tobacco use: Prevention, cessation, and control. Ann Intern Med. 2006; 145: 839–844.
Metadaten
Titel
Lifetime Characteristics of Participants and Non-participants in a Smoking Cessation Trial: Implications for External Validity and Public Health Impact
verfasst von
A. L. Graham, Ph.D.
G. D. Papandonatos, Ph.D.
J. D. DePue, Ed.D., M.P.H.
B. M. Pinto, Ph.D.
B. Borrelli, Ph.D.
C. J. Neighbors, Ph.D., MBA
R. Niaura, Ph.D.
S. L. Buka, Sc.D.
D. B. Abrams, Ph.D.
Publikationsdatum
01.06.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 3/2008
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-008-9031-1

Weitere Artikel der Ausgabe 3/2008

Annals of Behavioral Medicine 3/2008 Zur Ausgabe

Rapid Communication

The Use of Theory in Health Behavior Research from 2000 to 2005: A Systematic Review

Rapid Commuication

Small Changes in Nutrition and Physical Activity Promote Weight Loss and Maintenance: 3-Month Evidence from the ASPIRE Randomized Trial

Original Article

Effects of Mindfulness-Based Stress Reduction Intervention on Psychological Well-being and Quality of Life: Is Increased Mindfulness Indeed the Mechanism?

Original Article

Can Hostility Interfere with the Health Benefits of Giving and Receiving Social Support? The Impact of Cynical Hostility on Cardiovascular Reactivity During Social Support Interactions Among Friends

Original Article

Relation Between Central Adiposity and Cognitive Function in the Maine–Syracuse Study: Attenuation by Physical Activity

Original Article

Are Constructs of the Transtheoretical Model for Physical Activity Measured Equivalently Between Sexes, Age Groups, and Ethnicities?

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Bildnachweise